This framework generates organoids from diverse hiPSC sources, indicating a reliable approach for studying neurodevelopment and diseases.
Collectively, this methodological framework enables robust and reproducible generation of NOs from genetically diverse hiPSC sources, providing a reliable platform for studying human neurodevelopment and disease mechanisms in progeroid and other patient-specific contexts.
No takes yet. Share an insight, caveat, or question.
Fournier et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: